Reinhart Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-2,520
Closed -$292K 141
2015
Q2
$292K Sell
2,520
-120
-5% -$13.7K 0.03% 118
2015
Q1
$304K Hold
2,640
0.02% 170
2014
Q4
$295K Hold
2,640
0.02% 164
2014
Q3
$250K Hold
2,640
0.02% 166
2014
Q2
$227K Buy
+2,640
New +$201K 0.02% 172
2014
Q1
Sell
-2,540
Closed -$215K 185
2013
Q4
$215K Sell
2,540
-18,980
-88% -$1.5M 0.02% 161
2013
Q3
$1.66M Buy
21,520
+2,290
+12% +$160K 0.14% 122
2013
Q2
$1.13M Buy
+19,230
New +$1.16M 0.1% 137

Other funds holding CELG

Reinhart Partners's CELG Position: Q3 2015 in Review

Reinhart Partners sold out of Celgene Corp (CELG) in Q3 2015, closing a stake of 2,520 shares — an estimated $292K sold.

Reinhart Partners first reported a position in CELG in Q2 2013 and held it in 8 quarters. The position peaked at $1.66M in Q3 2013. 1,195 funds tracked by Wall St. Rank hold CELG as of Q3 2015.

  • Reinhart Partners reported no remaining Celgene Corp position as of Q3 2015 after selling out during the quarter.
  • Reinhart Partners sold 2,520 Celgene Corp shares in Q3 2015, an estimated $292K.
  • Reinhart Partners first reported a position in Celgene Corp in Q2 2013 and held it in 8 quarters.
  • Reinhart Partners's Celgene Corp position peaked at $1.66M in Q3 2013.
  • 1,195 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2015.

Based on Reinhart Partners's 13F filing for Q3 2015, filed 14 Oct 2015.